For many organisations, contamination control still looks like a documentation exercise. A CCS is written. Procedures are referenced. Responsibilities sit largely with QA. And yet, when inspectors start to probe, confidence often drops. This is not because teams are careless or under-skilled. It is because the way contamination control has traditionally been approached no longer aligns with how regulators are assessing it in practice. Auditor assessing Contamination Control d

If you make beauty products, your words are as important as your formulas. A single verb on pack or a bold line on your website can flip a product from cosmetic to drug in the eyes of regulators, bringing a completely different rulebook (and risk profile). Here's a practical guide to staying safely on the cosmetic side while still telling a compelling story. Claims Review in Action Why This Matters (Now More Than Ever) MoCRA didn't turn cosmetics into drugs, but it did raise

When people think of cleanrooms, they often picture sterile injectable medicines, with operators in full gowning working in Grade A or B environments. It is easy to assume that oral solid dose (OSD) manufacturing, with its tablets, capsules and powders, does not need the same level of rigour. After all, OSD products are not sterile. But the reality is that cleanroom controls in OSD facilities are just just as critical, though the risks and priorities look different. OSD Filli